Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.03.23 | Perma-Fix Environmental Services, Inc: Perma-Fix Reports Financial Results and Provides Business Update for 2022 | 430 | GlobeNewswire (Europe) | Treatment Segment on growth path heading into 2023with increased waste receipts and improved backlog Services Segment secures important projects expected to begin in Q2 2023 Reports... ► Artikel lesen | |
23.03.23 | ALSTOM SA: Disclosure of the total number of voting rights and shares forming the share capital as at 23 March 2023 | 423 | GlobeNewswire (Europe) | Disclosure of the total number of voting rights and sharesforming the share capital as at 23 March 2023 Information pursuant to article L. 233-8 II of the Code de commerce and articles 223-16 and 223-11... ► Artikel lesen | |
23.03.23 | Umicore: Transparency notification by Groupe Bruxelles Lambert SA | 585 | GlobeNewswire (Europe) | Transparency notification by Groupe Bruxelles Lambert SA In accordance with article 14, § 1 of the law of 2 May 2007 on disclosure of major holdings, Groupe Bruxelles Lambert SA (GBL SA) has recently... ► Artikel lesen | |
23.03.23 | Ohmyhome Announces Closing of Initial Public Offering | 324 | GlobeNewswire (Europe) | SINGAPORE, March 23, 2023 (GLOBE NEWSWIRE) -- Ohmyhome Limited (Nasdaq: OMH), a data-driven property technology company based in Singapore, today announced the closing of its initial public offering... ► Artikel lesen | |
23.03.23 | GeoVax, Inc.: GeoVax Reports 2022 Year-End Financial Results and Provides Corporate Update | 1.909 | GlobeNewswire (Europe) | Company Expands Ongoing Clinical Trials and theBreadth and Capacity of Its Novel Vaccine Platform Technology ATLANTA, GA, March 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - GeoVax Labs, Inc.... ► Artikel lesen | |
23.03.23 | Finch Therapeutics Group, Inc.: Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates | 479 | GlobeNewswire (Europe) | SOMERVILLE, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. ("Finch", "Finch Therapeutics" or the "Company") (Nasdaq: FNCH), a microbiome technology company with a portfolio... ► Artikel lesen | |
23.03.23 | Gain Therapeutics, Inc.: Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update | 735 | GlobeNewswire (Europe) | Company expects completion of IND-enabling studies of GT-02287 in H1 2023Submission of dossier to start Phase 1 clinical trial of GT-02287 in GBA1 Parkinson's Disease expected by mid-year 2023$22.1... ► Artikel lesen | |
23.03.23 | Paltalk, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results | 592 | GlobeNewswire (Europe) | Continued Sequential Quarterly Improvement in Net Loss and Reduced Operating Expenses JERICHO, NY, March 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Paltalk, Inc. ("Paltalk," the "Company," "we... ► Artikel lesen | |
23.03.23 | Quest Resource Holding Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results | 482 | GlobeNewswire (Europe) | THE COLONY, Texas, March 23, 2023 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ: QRHC) ("Quest"), a national leader in environmental waste and recycling services, today announced financial... ► Artikel lesen | |
23.03.23 | Vor Biopharma: Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update | 1.693 | GlobeNewswire (Europe) | Initial clinical data supports founding vision that engineered hematopoietic stem cells can enable treatment options after AML transplantAdditional trem-cel data expected by year-end 2023; VCAR33ALLO... ► Artikel lesen | |
23.03.23 | Invivyd Reports Full Year 2022 Financial Results and Business Highlights | 538 | GlobeNewswire (Europe) | Advancing VYD222 into clinical development based on in vitro data demonstrating neutralizing activity against multiple important variants of concern, including XBB.1.5 Anticipate near-term designation... ► Artikel lesen | |
23.03.23 | Ventyx Biosciences, Inc.: Ventyx Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Corporate Progress | 268 | GlobeNewswire (Europe) | Phase 2 trials of VTX958 (TYK2 inhibitor) are ongoing in plaque psoriasis, Crohn's disease and psoriatic arthritis, with topline Phase 2 data in plaque psoriasis expected in Q4 2023 The Phase 2 trial... ► Artikel lesen | |
23.03.23 | Erasca, Inc.: Erasca Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Business Updates | 319 | GlobeNewswire (Europe) | Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2,... ► Artikel lesen | |
23.03.23 | ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results | 366 | GlobeNewswire (Europe) | New Drug Application and Marketing Authorization Application for neffy® Currently Under Review with the FDA and EMA; FDA PDUFA Target Action Date Anticipated in Mid-2023 Strong Financial Position... ► Artikel lesen | |
23.03.23 | One Stop Systems, Inc.: OSS Reports Record Revenue up 17% to $72.4 Million and Adjusted EBITDA up 6% to $5.2 Million | 316 | GlobeNewswire (Europe) | ESCONDIDO, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (Nasdaq: OSS), a leader in AI Transportable solutions on the edge, reported results for the fourth quarter and full year... ► Artikel lesen | |
23.03.23 | Eargo Inc: Eargo Reports Fourth Quarter 2022 Financial Results | 433 | GlobeNewswire (Europe) | Recent Highlights: Net revenues of $12.9 million in the fourth quarter of 2022, compared to $10.1 million in the fourth quarter of 2021 and $7.9 million in the third quarter of 2022Gross systems shipped... ► Artikel lesen | |
23.03.23 | ADMA Biologics, Inc.: ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update | 348 | GlobeNewswire (Europe) | 4Q2022 Total Revenues of $50 Million, a 90% Y-o-Y Increase 4Q2022 Gross Profit of $14 Million, an $11 Million Y-o-Y Increase FY 2023 Total Revenue Expected to Exceed $210 Million First-Time Positive... ► Artikel lesen | |
23.03.23 | Athira Pharma, Inc.: Athira Pharma Reports Full Year 2022 Financial Results and Recent Pipeline and Business Updates | 379 | GlobeNewswire (Europe) | On track to complete enrollment in Phase 2/3 LIFT-AD trial of fosgonimeton for mild-to-moderate Alzheimer's disease in mid-2023 with topline data in early 2024 Continuing to advance development of... ► Artikel lesen | |
23.03.23 | BioAtla, Inc.: BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress | 189 | GlobeNewswire (Europe) | - Cleared dose-limiting toxicity (DLT) observation period with more frequent, dose-intensive regimen of CAB-AXL BA3011; anticipated leiomyosarcoma (LMS) cohort readout in 2H23 - Initiated the potentially... ► Artikel lesen | |
23.03.23 | WW International Inc.: WW International, Inc. Announces Upcoming Changes to Board of Directors | 765 | GlobeNewswire (Europe) | NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) ("WeightWatchers," "WW," or the "Company") announced several upcoming changes to its Board of Directors (the "Board")... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 3.298 |
EVOTEC | 2.639 |
TUI | 2.076 |
NEL | 1.327 |
BAYER | 1.149 |
PLUG POWER | 1.143 |
NVIDIA | 1.139 |
RHEINMETALL | 1.061 |
AMC ENTERTAINMENT | 1.035 |
DEUTSCHE BANK | 961 |
SIEMENS ENERGY | 936 |
RENK GROUP | 874 |
REDCARE PHARMACY | 727 |
COMMERZBANK | 726 |
HEIDELBERGER DRUCK | 701 |
ALIBABA | 679 |
VOLKSWAGEN | 671 |
E.ON | 619 |
BARRICK GOLD | 612 |
BYD | 592 |
RWE | 586 |
SIEMENS | 565 |
TESLA | 563 |
DEUTSCHE LUFTHANSA | 560 |
AIXTRON SE | 554 |